Long-term follow up of patients treated with limited PDT, for a symptomatic circumscribed choroidal hamangioma, in search of possible late unwanted side effects of PDT treatment and recurrence of leakage.
ID
Source
Brief title
Condition
- Retina, choroid and vitreous haemorrhages and vascular disorders
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The results of examinations will provide information of the effectiveness of
limited PDT after the first year(s), and possible late complications, including
recurrence.
Secondary outcome
nvt
Background summary
Circumscribed choroidal haemangioma (CCH) is an uncommon benign vascular tumor
of the choroid. Untreated, this tumor can result in permanent vision loss.
Photodynamic therapy (PDT) is at present the preferred treatment because of
good results and the low risk of complications.
Study objective
Long-term follow up of patients treated with limited PDT, for a symptomatic
circumscribed choroidal hamangioma, in search of possible late unwanted side
effects of PDT treatment and recurrence of leakage.
Study design
Prospective transversal observational cohort study.
All included patients will have a full ophthalmologic examination including
visual acuity, slitlamp biomicroscopy, Optical Coherence Tomography (OCT) with
enhanced depth imaging, Fundus Autofluorescence (FAF), Fluorescein angiography
in combination with Indocyanine Green Angiography (FA and ICGA) and
Ultrasonography.
Study burden and risks
nvt
Meibergdreef 9
Amsterdam 1105 AZ
NL
Meibergdreef 9
Amsterdam 1105 AZ
NL
Listed location countries
Age
Inclusion criteria
Patients treated for circumscribed choroidal haemangioma with PDT in the AMC
Exclusion criteria
none
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL52013.018.14 |